Inflammasome Priming in Sterile Inflammatory Disease.

The inflammasome is a cytoplasmic protein complex that processes interleukins (IL)-1β and IL-18, and drives a form of cell death known as pyroptosis. Oligomerization of this complex is actually the second step of activation, and a priming step must occur first. This involves transcriptional upregulation of pro-IL-1β, inflammasome sensor NLRP3, or the non-canonical inflammasome sensor caspase-11. An additional aspect of priming is the post-translational modification of particular inflammasome constituents. Priming is typically accomplished in vitro using a microbial Toll-like receptor (TLR) ligand. However, it is now clear that inflammasomes are activated during the progression of sterile inflammatory diseases such as atherosclerosis, metabolic disease, and neuroinflammatory disorders. Therefore, it is time to consider the endogenous factors and mechanisms that may prime the inflammasome in these conditions.

[1]  G. van Loo,et al.  Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis , 2014, Nature.

[2]  J. Köhl,et al.  C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. , 2013, Blood.

[3]  Shuzhen Chen,et al.  Negative regulation of NLRP3 inflammasome signaling , 2013, Protein & Cell.

[4]  J. Hiscott,et al.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.

[5]  N. Bergeron,et al.  Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. , 2005, The Journal of clinical endocrinology and metabolism.

[6]  T. Roger,et al.  Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 Inflammasome In Vitro , 2011, The Journal of Immunology.

[7]  Xuebin Qin,et al.  Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice , 2016, Scientific Reports.

[8]  K. Schroder,et al.  NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5 , 2015, European journal of immunology.

[9]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[10]  James R. Springstead,et al.  An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells , 2016, Science.

[11]  E. Alnemri,et al.  Inflammasome Priming by Lipopolysaccharide Is Dependent upon ERK Signaling and Proteasome Function , 2014, The Journal of Immunology.

[12]  R. Lockey,et al.  MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2. , 2013, Biochemical and biophysical research communications.

[13]  S. Ryter,et al.  UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis , 2023, The Journal of clinical investigation.

[14]  S. Ryter,et al.  Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. , 2011, Nature immunology.

[15]  K. Fransén,et al.  Role of NLRP3 and CARD8 in the regulation of TNF-α induced IL-1β release in vascular smooth muscle cells. , 2012, International journal of molecular medicine.

[16]  Alessandra Pedrocchi,et al.  Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid , 2016, Mediators of inflammation.

[17]  Kamila Belhocine,et al.  Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1 , 2012, Nature.

[18]  G. Núñez,et al.  Critical role for mast cells in interleukin-1β-driven skin inflammation associated with an activating mutation in the nlrp3 protein. , 2012, Immunity.

[19]  Nan Li,et al.  Immune Responsive Gene 1 (IRG1) Promotes Endotoxin Tolerance by Increasing A20 Expression in Macrophages through Reactive Oxygen Species* , 2013, The Journal of Biological Chemistry.

[20]  M. Brucale,et al.  Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies , 2013, PloS one.

[21]  H. Kwon,et al.  Adipokines Mediate Inflammation and Insulin Resistance , 2013, Front. Endocrinol..

[22]  T. Ichinohe,et al.  Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection , 2013, Proceedings of the National Academy of Sciences.

[23]  S. Maier,et al.  The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome , 2016, Brain, Behavior, and Immunity.

[24]  Zhonghan Li,et al.  Therapeutic targeting of microRNAs: current status and future challenges , 2014, Nature Reviews Drug Discovery.

[25]  J. Walkowiak,et al.  Butyric acid in functional constipation , 2013, Przeglad gastroenterologiczny.

[26]  E. Alnemri,et al.  Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation* , 2012, The Journal of Biological Chemistry.

[27]  F. Meissner,et al.  Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis , 2010, Proceedings of the National Academy of Sciences.

[28]  F. Azuaje,et al.  Permanent Culture of Macrophages at Physiological Oxygen Attenuates the Antioxidant and Immunomodulatory Properties of Dimethyl Fumarate , 2015, Journal of cellular physiology.

[29]  M. Lamkanfi,et al.  Reactive Oxygen Species Regulate Caspase-11 Expression and Activation of the Non-canonical NLRP3 Inflammasome during Enteric Pathogen Infection , 2014, PLoS pathogens.

[30]  F. Holz,et al.  Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative Damage* , 2015, The Journal of Biological Chemistry.

[31]  Denis Gris,et al.  Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.

[32]  Daniel E. Zak,et al.  Caspase-11 Protects Against Bacteria That Escape the Vacuole , 2013, Science.

[33]  M. Lamkanfi,et al.  Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation , 2015, Scientific Reports.

[34]  Junying Yuan.  Faculty Opinions recommendation of Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. , 2015 .

[35]  G. Johnson,et al.  Mapping of the C5a receptor signal transduction network in human neutrophils. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Müller-Eberhard,et al.  The membrane attack complex of complement. , 1986, Annual review of immunology.

[37]  J. Ehses,et al.  Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates* , 2016, The Journal of Biological Chemistry.

[38]  B. Morgan,et al.  The membrane attack complex as an inflammatory trigger. , 2016, Immunobiology.

[39]  F. Sutterwala,et al.  Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation , 2016, Journal of Cell Science.

[40]  J. Simard,et al.  S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-κB1 , 2013, PloS one.

[41]  D. Powell,et al.  Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock , 2013, Science.

[42]  Jennifer R. Clark,et al.  Complement-mediated regulation of the interleukin 17A axis is a central genetic determinant of the severity of experimental allergic asthma , 2010, Nature Immunology.

[43]  M. Wills-Karp,et al.  Complement-mediated Regulation Of The IL-17A Axis Is A Central Genetic Determinant Of The Severity Of Experimental Allergic Asthma , 2010, ATS 2010.

[44]  E. Ravussin,et al.  The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.

[45]  V. Hornung,et al.  Aging-Associated TNF Production Primes Inflammasome Activation and NLRP3-Related Metabolic Disturbances , 2016, The Journal of Immunology.

[46]  C. Murga,et al.  The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. , 2007, Biochimica et biophysica acta.

[47]  M. Brown,et al.  SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  E. Gratton,et al.  LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling , 2015, eLife.

[49]  R. Egan,et al.  Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides. , 1990, Journal of immunology.

[50]  K. Shin,et al.  Suppression of caspase-11 expression by histone deacetylase inhibitors. , 2009, Biochemical and biophysical research communications.

[51]  D. Green,et al.  FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes , 2014, The Journal of Immunology.

[52]  Y. Itoyama,et al.  Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice. , 2003, Biochemical and biophysical research communications.

[53]  M. Shong,et al.  Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes , 2012, Diabetes.

[54]  G. López-Castejón,et al.  Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the Inflammasome , 2012, The Journal of Biological Chemistry.

[55]  D. Choubey,et al.  Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation , 2016, Oncotarget.

[56]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[57]  Anna K Rieger,et al.  Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome , 2011, The Journal of Immunology.

[58]  E. Latz,et al.  Crystal Formation in Inflammation. , 2016, Annual review of immunology.

[59]  F. Van de Werf,et al.  Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[60]  Charles C. Kim,et al.  Saturated Fatty Acids Engage an IRE1α-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells. , 2016, Cell reports.

[61]  D. Monack,et al.  Bacterial recognition pathways that lead to inflammasome activation , 2015, Immunological reviews.

[62]  Xiangmei Zhou,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[63]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[64]  S. Masters,et al.  Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. , 2011, Trends in molecular medicine.

[65]  B. Morgan.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. , 1989, The Biochemical journal.

[66]  M. Lamkanfi,et al.  Toll or Interleukin-1 Receptor (TIR) Domain-containing Adaptor Inducing Interferon-β (TRIF)-mediated Caspase-11 Protease Production Integrates Toll-like Receptor 4 (TLR4) Protein- and Nlrp3 Inflammasome-mediated Host Defense against Enteropathogens* , 2012, The Journal of Biological Chemistry.

[67]  R. Vance.  Inflammasome activation: how macrophages watch what they eat. , 2010, Cell host & microbe.

[68]  Eun-Hee Kim,et al.  Cobalt Chloride-induced Hypoxia Ameliorates NLRP3-Mediated Caspase-1 Activation in Mixed Glial Cultures , 2013, Immune network.

[69]  G. Núñez,et al.  Sensing and reacting to microbes through the inflammasomes , 2012, Nature Immunology.

[70]  B. Jaber,et al.  C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. , 2002, Kidney international.

[71]  L. Orci,et al.  Lipid homeostasis, lipotoxicity and the metabolic syndrome. , 2010, Biochimica et biophysica acta.

[72]  I. Spasojević,et al.  A Comparative Analysis of Multiple Sclerosis–Relevant Anti-Inflammatory Properties of Ethyl Pyruvate and Dimethyl Fumarate , 2015, The Journal of Immunology.

[73]  Jelena S. Bezbradica,et al.  Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals , 2016, Cellular & Molecular Immunology.

[74]  P. Ward,et al.  Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes , 2016, Mediators of inflammation.

[75]  S. Rubin,et al.  The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. , 2004, Diabetes.

[76]  J. Gugenheim,et al.  ER stress induces NLRP3 inflammasome activation and hepatocyte death , 2015, Cell Death and Disease.

[77]  Soonkyu Chung,et al.  Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes[S] , 2016, Journal of Lipid Research.

[78]  M. T. Wong,et al.  Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4 , 2013, Science.

[79]  Yajing Wang,et al.  Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation. , 2016, Biochemical pharmacology.

[80]  J. Lambris,et al.  Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and Cytokine Release , 2014, The Journal of Immunology.

[81]  E. Pearce,et al.  Immunometabolism governs dendritic cell and macrophage function , 2016, The Journal of experimental medicine.

[82]  E. Lien,et al.  Early Upregulation of NLRP3 in the Brain of Neonatal Mice Exposed to Hypoxia-Ischemia: No Early Neuroprotective Effects of NLRP3 Deficiency , 2015, Neonatology.

[83]  J. Capeau,et al.  Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes , 2006, Diabetologia.

[84]  T. Reimer,et al.  Complement C5a potentiates uric acid crystal‐induced IL‐1β production , 2014, European journal of immunology.

[85]  G. Szabo,et al.  Inflammasomes in liver diseases. , 2012, Journal of hepatology.

[86]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.

[87]  J. Cavaillon,et al.  C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. , 1987, Journal of immunology.

[88]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[89]  A. Wree,et al.  NLRP3 inflammasome activation is required for fibrosis development in NAFLD , 2014, Journal of Molecular Medicine.

[90]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[91]  Sky W. Brubaker,et al.  Complement pathway amplifies caspase-11–dependent cell death and endotoxin-induced sepsis severity , 2016, The Journal of experimental medicine.

[92]  S. Weisnagel,et al.  Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women. , 2007, Atherosclerosis.

[93]  T. Hughes,et al.  Cutting Edge: The NLRP3 Inflammasome Links Complement-Mediated Inflammation and IL-1β Release , 2013, The Journal of Immunology.

[94]  Peter Schotte,et al.  Caspase-11 Gene Expression in Response to Lipopolysaccharide and Interferon-γ Requires Nuclear Factor-κB and Signal Transducer and Activator of Transcription (STAT) 1* , 2002, The Journal of Biological Chemistry.

[95]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[96]  Denise N. Bronner,et al.  Endoplasmic Reticulum stress activates the inflammasome via NLRP 3-caspase-2 driven mitochondrial damage , 2015 .

[97]  S. Akira,et al.  Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation , 2014, Proceedings of the National Academy of Sciences.

[98]  Sarah L. Doyle,et al.  Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives , 2015, Journal of inflammation research.

[99]  Si Ming Man,et al.  IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes , 2016, Cell.

[100]  M. Haneklaus,et al.  Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. , 2013, Current opinion in immunology.

[101]  Inhwa Hwang,et al.  Histone deacetylase 6 negatively regulates NLRP3 inflammasome activation. , 2015, Biochemical and biophysical research communications.

[102]  R. Deshaies.  Protein degradation: Prime time for PROTACs. , 2015, Nature chemical biology.

[103]  Christine E. Becker,et al.  TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria , 2012, Cell.

[104]  F. Sutterwala,et al.  Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome , 2009, Proceedings of the National Academy of Sciences.

[105]  G. Núñez,et al.  Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1 , 2009, The Journal of Immunology.

[106]  R. C. Ho,et al.  Whole-body insulin sensitivity, low-density lipoprotein (LDL) particle size, and oxidized LDL in overweight, nondiabetic men. , 2002, Metabolism: clinical and experimental.

[107]  E. Alnemri,et al.  Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome , 2013, The Journal of Immunology.

[108]  Christine E. Becker,et al.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes , 2010, Nature Immunology.

[109]  L. Joosten,et al.  Inflammasome is a central player in the induction of obesity and insulin resistance , 2011, Proceedings of the National Academy of Sciences.

[110]  Helmut Neumann,et al.  Caspase-8 regulates TNF-alpha induced epithelial necroptosis and terminal ileitis , 2011, Nature.

[111]  Haitao Wen,et al.  The inflammasome NLRs in immunity, inflammation, and associated diseases. , 2011, Annual review of immunology.

[112]  Anna K Rieger,et al.  NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223 , 2012, The Journal of Immunology.

[113]  F. Wright,et al.  Identification of a locus on chromosome 1q44 for familial cold urticaria. , 2000, American journal of human genetics.

[114]  D. Jacobs,et al.  The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2007, Atherosclerosis.

[115]  José Antonio López Escamez.  Faculty of 1000 evaluation for Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. , 2018 .

[116]  Vikas Gupta,et al.  MicroRNA therapeutics: Discovering novel targets and developing specific therapy , 2016, Perspectives in clinical research.

[117]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[118]  U. Mrowietz,et al.  Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation , 2010, Journal of Neuroinflammation.

[119]  C. Bryant,et al.  Molecular mechanisms involved in inflammasome activation. , 2009, Trends in cell biology.

[120]  M. Chatzopoulou,et al.  RAGE: a multi-ligand receptor unveiling novel insights in health and disease. , 2010, Current medicinal chemistry.

[121]  T. Hughes,et al.  The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation , 2013, Journal of Cell Science.

[122]  S. Frede,et al.  Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. , 2006, The Biochemical journal.

[123]  J. Yewdell,et al.  Post-transcriptional control of NLRP3 inflammasome activation in colonic macrophages , 2015, Mucosal Immunology.

[124]  Maxim N. Artyomov,et al.  Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. , 2016, Cell metabolism.

[125]  T. Kanneganti,et al.  Autoinflammatory Skin Disorders: The Inflammasomme in Focus. , 2016, Trends in molecular medicine.

[126]  田中 弘之,et al.  軟骨無形成症発症機序におけるSignal Transducer and Activator of Transcription (Stat)1の機能的役割 , 2001 .

[127]  J. Qu,et al.  Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients. , 2015, Experimental eye research.

[128]  G. Fantuzzi,et al.  Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[129]  G. Núñez,et al.  Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.

[130]  Junying Yuan,et al.  Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. , 2013, Molecular cell.

[131]  M. Idzko,et al.  MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation. , 2015, Blood.

[132]  F. Martinon.  Detection of immune danger signals by NALP3 , 2008, Journal of leukocyte biology.

[133]  Huiping Jiang,et al.  Pertussis Toxin-sensitive Activation of Phospholipase C by the C5a and fMet-Leu-Phe Receptors* , 1996, The Journal of Biological Chemistry.

[134]  F. Sutterwala,et al.  Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. , 2013, Immunity.

[135]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[136]  P. Libby,et al.  Moderate Hypoxia Potentiates Interleukin-1&bgr; Production in Activated Human Macrophages , 2014, Circulation research.

[137]  C. Schneider,et al.  Ceramide triggers an NF-κB-dependent survival pathway through calpain , 2005, Cell Death and Differentiation.

[138]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[139]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[140]  Yuhong Yang,et al.  Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling* , 2012, The Journal of Biological Chemistry.

[141]  H. Roche,et al.  Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. , 2012, Molecular nutrition & food research.

[142]  J. Tschopp,et al.  NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? , 2010, Nature Reviews Immunology.

[143]  A. la Sala,et al.  Gi-Protein-Dependent Inhibition of IL-12 Production Is Mediated by Activation of the Phosphatidylinositol 3-Kinase-Protein 3 Kinase B/Akt Pathway and JNK , 2005, The Journal of Immunology.

[144]  J. Ehses,et al.  Resident Macrophages Mediate Islet Amyloid Polypeptide–Induced Islet IL-1β Production and β-Cell Dysfunction , 2014, Diabetes.

[145]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[146]  Y. Le Marchand-Brustel,et al.  Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. , 2007, Endocrinology.

[147]  D. Su,et al.  NLRP3 inflammasome and its inhibitors: a review , 2015, Front. Pharmacol..

[148]  A. Admon,et al.  SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene , 1993, Cell.

[149]  P. Li,et al.  Inflammatory caspases are innate immune receptors for intracellular LPS , 2014, Nature.

[150]  S. Ryter,et al.  mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation. , 2015, Cell reports.

[151]  Traci L. Marin,et al.  Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility , 2013, Circulation.

[152]  J. Kuemmerle-Deschner.  CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease , 2015, Seminars in Immunopathology.

[153]  TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[154]  Jian-Mei Li,et al.  Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377. , 2015, Free radical biology & medicine.

[155]  Moshe Arditi,et al.  Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.